4//SEC Filing
MCCLUNG BARBARA G 4
Accession 0001209191-21-068582
CIK 0001619856other
Filed
Dec 7, 7:00 PM ET
Accepted
Dec 8, 6:06 PM ET
Size
11.6 KB
Accession
0001209191-21-068582
Insider Transaction Report
Form 4
MCCLUNG BARBARA G
Chief Legal Officer
Transactions
- Purchase
Common Stock
2021-12-07$2.69/sh+12$32→ 342,856 total - Purchase
Common Stock
2021-12-07$2.69/sh+6,115$16,449→ 348,971 total - Exercise of In-Money
Option to purchase Common Stock
2021-12-07−12→ 77 totalExercise: $2.69Exp: 2028-06-11→ Common Stock (12 underlying) - Exercise of In-Money
Option to purchase Common Stock
2021-12-07−6,115→ 74,836 totalExercise: $2.69Exp: 2029-09-30→ Common Stock (6,115 underlying)
Footnotes (4)
- [F1]These shares were acquired pursuant to the exercise of a stock option, as reported in Table II below.
- [F2]The exercise price for this stock option was incorrectly reported as $2.68 per share on the reporting person's Form 3 filed on July 22, 2021.
- [F3]The shares subject to this option have vested or will vest in equal monthly installments until the option is fully vested on June 12, 2022, subject to the reporting person's continued service to the Issuer through the applicable vesting dates.
- [F4]The shares subject to this option have vested or will vest in equal monthly installments until the option is fully vested on October 1, 2023, subject to the reporting person's continued service to the Issuer through the applicable vesting dates.
Documents
Issuer
Caribou Biosciences, Inc.
CIK 0001619856
Entity typeother
Related Parties
1- filerCIK 0001231321
Filing Metadata
- Form type
- 4
- Filed
- Dec 7, 7:00 PM ET
- Accepted
- Dec 8, 6:06 PM ET
- Size
- 11.6 KB